Tracking Response to Antidepressants in Advance of Investigational Trials
Conditions
- Major Depressive Disorder
Interventions
- DRUG: FDA-approved selective-serotonin reuptake inhibitors (SSRIs) and selective-norepinephrine reuptake inhibitors (SNRIs)
Sponsor
Adams Clinical